MSF.F Microsoft (XETRA) €382.35 close 23 Jan 2026: earnings cues
The MSF.F stock closed at €382.35 on 23 Jan 2026, trading in a narrow intraday range as investors position ahead of Microsoft Corporation’s Jan 28 earnings release. Key short-term drivers are Azure AI growth expectations, recent service outages, and analyst revisions that have trimmed price targets. Today’s session showed volume 37,991.00 and a modest YTD move of -2.06%, setting a low-volatility backdrop before results.
MSF.F stock: Earnings timing and what to expect
Microsoft reports results on 28 Jan 2026, with the company scheduled to announce after US market hours. Expectations focus on Intelligent Cloud revenue and AI services margins; several outlets flag potential reacceleration in cloud gross margins as the main beat-or-miss factor. Analyst previews cited in the market show mixed positioning with some modelers expecting a modest beat while others warn of margin noise tied to Copilot and cloud investments.
MSF.F stock: Recent price action and news drivers
MSF.F stock traded between €379.45 and €384.60 today and sits -12.49% over three months versus a Technology sector three-month gain of 6.42%. Newsflow this week included service outages that weighed on sentiment and reports of analyst cuts to price targets, both of which compressed short-term trading ranges. Investors are also watching regulatory and security headlines and a steady stream of AI strategy updates from Microsoft that can swing post-earnings guidance.
MSF.F stock: Fundamentals and valuation snapshot
Microsoft shows a trailing EPS €12.00 and PE 32.98, with market capitalisation near €2,940,991,922,368.00. The company’s price-to-sales 11.40 and price-to-book 9.23 reflect premium tech multiples versus the Technology sector average PE 36.24, but Microsoft earns stronger ROE at 31.53% and operating margins near 46.27%. Revenue and free cash flow growth remain healthy; ten-year revenue-per-share growth is robust, supporting a premium valuation despite a stretched PB.
MSF.F stock: Technicals, liquidity and Meyka grade
Technically, MSF.F stock shows RSI 47.91 and MACD histogram 1.00, suggesting neutral momentum ahead of earnings. Average daily volume is 3,185.00 with today’s volume at 37,991.00, indicating higher-than-normal activity but continued liquidity on XETRA. Meyka AI rates MSF.F with a score out of 100: 79.81 (B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guarantees and we are not financial advisors.
MSF.F stock: Meyka AI forecast and price targets
Meyka AI’s forecast model projects a yearly price €562.75, a quarterly €449.71 and a monthly €453.70 target based on multi-horizon fundamentals and sector momentum. Compared with the current €382.35, the model implies an upside of +47.17% to the yearly target and +18.67% to the monthly target. Forecasts are model-based projections and not guarantees. For context, consensus street targets vary; some banks trimmed near-term targets while still forecasting mid-single-digit to mid-teens revenue growth tied to AI adoption.
MSF.F stock: Risks and opportunities into earnings
Primary upside risks are stronger-than-expected Azure AI revenue and margin expansion, continued subscription growth in Productivity, and positive guidance on enterprise spending. Downside risks include weaker ad or Windows OEM demand, margin pressure from AI infrastructure costs, and negative reaction to any guidance cut tied to cloud investments. Investors should weigh these outcomes against a strong balance sheet, high interest coverage 54.35, and steady buyback and dividend policies as stabilisers.
Final Thoughts
MSF.F stock sits at €382.35 coming into the Jan 28, 2026 earnings report with a clear earnings trade: beat on Azure AI revenue and margins could reflate the valuation; a cautious guide would likely cap upside. Our Meyka AI model projects €562.75 over 12 months, implying +47.17% versus today’s close, while nearer-term monthly support-to-target sits around €453.70 (+18.67%). Valuation remains premium with PE 32.98 but is supported by robust margins, ROE 31.53%, and strong free cash flow. Traders should watch cloud gross margins, guidance language on AI spending, and any operational notices that follow outages. We reference coverage on macro sentiment and immediate newsflow for context: see the latest quotes and reporting on Microsoft on CNBC and detailed XETRA listings at StockAnalysis; internal details and live metrics are available on the Meyka MSF.F page for subscribers. Forecasts are model-based projections and not guarantees, and Meyka AI is an AI-powered market analysis platform providing data-driven context, not personalised advice.
FAQs
When does Microsoft report earnings and why does it matter for MSF.F stock?
Microsoft reports on 28 Jan 2026. The release matters because Azure and AI service margins will drive guidance and short-term stock moves for MSF.F stock, especially given current analyst positioning and recent service outage headlines.
What is Meyka AI’s price forecast for MSF.F stock?
Meyka AI’s forecast model projects a yearly €562.75, implying +47.17% from the current €382.35. These are model projections and not guarantees; investors should use them alongside full earnings results.
How is MSF.F stock valued versus the Technology sector?
MSF.F stock trades at PE 32.98 versus the sector average PE 36.24, with a higher PB 9.23. Premium valuation reflects stronger ROE and margins, balanced by elevated price-to-sales and price-to-free-cash-flow ratios.
What are the main risks to MSF.F stock after the earnings report?
Key risks are disappointing Azure AI revenue, margin pressure from infrastructure spend, weaker enterprise demand, and negative guidance. Operational disruptions or regulatory headlines can also amplify downside for MSF.F stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
